Lower levels of ACE2 gene expression in nasal epithelium, the first point of contact for SARS-CoV-2 and the human body, may explain why children have a lower risk of Covid-19 infection and mortality, according to a study.
The SARS-CoV-2 virus uses ACE2 to enter the host. ACE2 nasal gene expression could potentially be used as a biomarker to evaluate Covid-19 susceptibility, said the researchers from Icahn School of Medicine at Mount Sinai in the US.
The study, published in the journal JAMA, analysed 305 patients aged four to 60 years at the Mount Sinai Health System in New York.
The researchers found that ACE2 gene expression in nasal epithelium was lowest in younger children and increased with age.
These findings could help explain why children appear to be less susceptible to Covid-19 infection, they said.
The researchers said the results may point to a potential biomarker of Covid-19 susceptibility.
Prospective studies are needed to assess the degree to which ACE2 expression can be used as a biomarker for COVID-19 susceptibility, they said.
"Why children get COVID-19 less than adults has been a puzzle. Researchers have hypothesised that lower expression of ACE2, which the SARS-Cov-2 virus uses to enter our bodies, might explain why children are less likely to get COVID-19," said Supinda Bunyavanich of Icahn School of Medicine at Mount Sinai.
"Our study shows that ACE2 expression in the nasal epithelium is lowest in younger children and increases with age into adulthood, Bunyavanich.
The results may help explain why children account for less than two per cent of identified cases of Covid-19, the researchers added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
